DOR is an essential endpoint in clinical trials and real-world studies. It provides insights into the sustainability of a treatment's benefits, helping oncologists make informed decisions about treatment planning. Moreover, a longer DOR can significantly improve a patient's quality of life by extending the period during which the cancer is managed effectively.
